Clinical trial
Standard Therapy Given With or Without Combination Chemotherapy in Treating…
NCT00003240 · National Cancer Institute (NCI), NIH · Unknown status
Key facts
| NCT number | NCT00003240 |
|---|---|
| Title | Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer |
| Official title | A Major Randomised Trial to Determine the Value of Cisplatin-Based Chemotherapy For All Patients With Non-Small Cell Lung Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, ifosfamide, mitomycin C, vinblastine sulfate, vindesine, vinorelbine tartrate, conventional surgery, radiation therapy |
| Enrollment | 1,800 |
| Start date | Oct 1, 1995 |
| First posted | Feb 20, 2004 |
| Last update posted | Dec 18, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: